SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-24-016515
Filing Date
2024-02-23
Accepted
2024-02-23 16:23:46
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0200444-s3_citiuspharma.htm S-3 327282
2 FORM OF INDENTURE ea0200444ex4-22_citiuspharma.htm EX-4.22 400697
3 OPINION OF WYRICK ROBBINS YATES & PONTON, LLP ea0200444ex5-1_citiuspharma.htm EX-5.1 30699
4 CONSENT OF WOLF & COMPANY, P.C. ea0200444ex23-1_citiuspharma.htm EX-23.1 3187
5 FILING FEE TABLE ea0200444ex-fee_citiuspharma.htm EX-FILING FEES 64427
6 GRAPHIC image_001.jpg GRAPHIC 5079
  Complete submission text file 0001213900-24-016515.txt   834639
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-277319 | Film No.: 24671573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)